Global ICON survey shows need for more efficient obesity clinical trial design to realise full potential of next-gen multi-indication therapies Read more about Global ICON survey shows need for more efficient obesity clinical trial design to realise full potential of next-gen multi-indication therapies
ICON plc Schedules First Quarter 2025 Earnings Conference Call Read more about ICON plc Schedules First Quarter 2025 Earnings Conference Call
ICON plc to Present at Upcoming Investor Conferences Read more about ICON plc to Present at Upcoming Investor Conferences
ICON Reports Fourth Quarter and Full Year 2024 Results Read more about ICON Reports Fourth Quarter and Full Year 2024 Results
ICON Portfolio of AI Tools Drives Clinical Trial Efficiencies Read more about ICON Portfolio of AI Tools Drives Clinical Trial Efficiencies
ICON plc Schedules Fourth Quarter and Full Year 2024 Earnings Conference Call Read more about ICON plc Schedules Fourth Quarter and Full Year 2024 Earnings Conference Call
ICON Issues Financial Guidance for Full Year 2025 Read more about ICON Issues Financial Guidance for Full Year 2025
Biomarker and Trial Optimisation Needed to Drive R&D Progress in Alzheimer’s and Related Disorders – ICON Survey Read more about Biomarker and Trial Optimisation Needed to Drive R&D Progress in Alzheimer’s and Related Disorders – ICON Survey
ICON plc to Present at the 43rd Annual J.P. Morgan Healthcare Conference Read more about ICON plc to Present at the 43rd Annual J.P. Morgan Healthcare Conference
